Study ties longer use of tamoxifen to lower risk of cancer recurrence

06/3/2013 | Reuters

Longer tamoxifen use was associated with lower risk of breast cancer recurrence and death, according to a study presented at the American Society of Clinical Oncology meeting. Researchers found women who continued using tamoxifen for 10 years had a 25% lower rate of cancer recurrence and were 23% less likely to die of breast cancer than those who took the drug for five years.

View Full Article in:

Reuters

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Manager, Business Conduct
Gilead
Foster City, CA
Product Patent Attorney
Gilead
Foster City, CA
Employment Counsel
Gilead
Foster City, CA
Junior to Mid-Level FDA Associate
Morgan Lewis
Washington, DC
Global Counsel - Advertising and Promotions
Mylan Inc.
Washington, DC